Intramuscular Olanzapine and Intramuscular Haloperidol in Acute Schizophrenia: Antipsychotic Efficacy and Extrapyramidal Safety during the First 24 Hours of Treatment

Author:

Wright Padraig1,Lindborg Stacy R2,Birkett Martin3,Meehan Karena4,Jones Barry5,Alaka Karla6,Ferchland-Howe Iris7,Pickard Anne8,Taylor Cindy C9,Roth John10,Battaglia John11,Bitter István12,Chouinard Guy13,Morris Philip LP14,Breier Alan15

Affiliation:

1. Leader, Clinical Neuroscience, Lilly Research Centre, Eli Lilly and Company, Surrey, UK; Honorary Senior Lecturer, Institute of Psychiatry, University of London, London, UK

2. Research Scientist, Statistical and Mathematical Sciences, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

3. Clinical Operations Manager, Lilly UK, Basingstoke, Hampshire, UK

4. Specialist Registrar, Maudsley Hospital, London, UK

5. Senior Clinical Research Physician, Eli Lilly Canada, Toronto, Ontario

6. Senior Scientific Communications Associate, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

7. Clinical Research Team Leader, Lilly Research Centre, Eli Lilly and Company, Surrey, UK

8. Clinical Research Team Leader, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

9. Associate Scientific Communications Consultant, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

10. Senior Regulatory Research Scientist, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

11. Associate Professor of Psychiatry, University of Wisconsin Medical School, Madison, Wisconsin

12. Professor of Psychiatry, Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary

13. Professor of Psychiatry, University of Montreal and McGill University, Louis-H Lafontaine Hospital, Montreal, Quebec; Director, Clinical Psychopharmacology Unit, McGill University Health Centre, Montreal, Quebec

14. Professor, Department of Psychiatry, University of Queensland, Brisbane, Australia

15. Vice President of Medical and Chief Medical Officer, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

Publisher

SAGE Publications

Subject

Psychiatry and Mental health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3